Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Pharmacoeconomic Considerations in Antiarrhythmic Therapy
Philip J. Podrid
,
Renée J.G. Arnold
, Diana J. Kaniecki
Research output
:
Contribution to journal
›
Review article
›
peer-review
3
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pharmacoeconomic Considerations in Antiarrhythmic Therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Adverse Effects
100%
Antiarrhythmic Therapy
100%
Pharmacoeconomics
100%
Initial Treatment
33%
Ventricular Arrhythmia
33%
Pharmacotherapy
33%
Focus of Attention
33%
Arrhythmia Suppression
33%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacoeconomics
100%
Antiarrhythmic Drug
100%
Pharmacotherapy
50%
Heart Arrhythmia
50%